Weicai Chen
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- RNA modifications and cancer 5
- RNA Research and Splicing 3
- RNA Interference and Gene Delivery 3
-
- Cancer-related molecular mechanisms research 4
- Co-authors
- Jifeng Chen (2 shared papers)Xintao Shuai (2 shared papers)Du Cheng (2 shared papers)Lu Wang (1 shared paper)Yuanyuan Yuan (1 shared paper)Xianming Wang (4 shared papers)Xi Liu (1 shared paper)Meifang Dong (1 shared paper)
- Journals
- Glycobiology (2 papers)Small (1 paper)Biotechnology and Applied Biochemistry (1 paper)Journal of Cellular and Molecular Medicine (1 paper)Medicine (1 paper)
- Partner nations
- ChinaUnited StatesThailand
In The Last Decade
Weicai Chen
31 papers receiving 716 citations
Peers
Comparison fields: 5 of 88
- Cancer Research 157
- Biomaterials 117
- Biochemistry 48
- Molecular Biology 495
- Gastroenterology 20
Countries citing papers authored by Weicai Chen
This map shows the geographic impact of Weicai Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weicai Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weicai Chen more than expected).
Fields of papers citing papers by Weicai Chen
This network shows the impact of papers produced by Weicai Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weicai Chen. The network helps show where Weicai Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Weicai Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 143 | |
| 2 | 2002 | 91 | |
| 3 | 2013 | 78 | |
| 4 | 2013 | 74 | |
| 5 | 2018 | 41 | |
| 6 | 2017 | 28 | |
| 7 | 2019 | 24 | |
| 8 | 2016 | 23 | |
| 9 | 2020 | 21 | |
| 10 | 2014 | 19 | |
| 11 | 2021 | 18 | |
| 12 | 2016 | 18 | |
| 13 | 2015 | 17 | |
| 14 | 2018 | 17 | |
| 15 | 2004 | 16 | |
| 16 | 2019 | 14 | |
| 17 | 2022 | 13 | |
| 18 | 2015 | 11 | |
| 19 | 2022 | 10 | |
| 20 | [Protective effects of puerarin against myocardial injury in patients with hypertension during perioperational period]. | 2006 | 9 |
About Weicai Chen
Weicai Chen is a scholar working on Molecular Biology, Cancer Research, Oncology, Surgery and Genetics, having authored 32 papers that have together received 726 indexed citations. Recurring topics across this work include RNA modifications and cancer (5 papers), Cancer-related molecular mechanisms research (4 papers), Mesenchymal stem cell research (3 papers), RNA Research and Splicing (3 papers), Cancer-related Molecular Pathways (3 papers), RNA Interference and Gene Delivery (3 papers), Cancer Treatment and Pharmacology (2 papers) and Galectins and Cancer Biology (2 papers). The work is most often cited by research in Cancer Research (157 citations), Biomaterials (117 citations), Biochemistry (48 citations), Molecular Biology (495 citations) and Gastroenterology (20 citations). Weicai Chen has collaborated with scholars based in China, United States and Thailand. Frequent co-authors include Jifeng Chen, Xintao Shuai, Du Cheng, Lu Wang, Yuanyuan Yuan, Xianming Wang, Xi Liu, Meifang Dong, Yuanji Han and Xiaohui Wang. Their work appears in journals such as Glycobiology, Small, Biotechnology and Applied Biochemistry, Journal of Cellular and Molecular Medicine and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.